MAster Protocol Studying the Impact of Blood Biopsy on Screening, Diagnosis, Diagnostic and Follow-up of Solid Cancer in Adult
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 6,000
- 试验地点
- 12
- 主要终点
- Liquid biopsy analyses
研究概览
简要总结
This exploratory study will focus on the development of the analyses of blood biomarkers to better understand the circulating biomarkers associated with cancer diagnosis, treatment efficacy and progressive disease
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult (>18y)
- •Owing a social security insurance
- •Any solid cancer diagnosed by histopathology or cytology
- •Patient with blood sampling required as per standard of care
- •Informed consent signed
排除标准
- •Refusal to participate
- •No blood sampling required as per standard of care
- •Hemoglobin < 7g/dl (< 9g/dl if respiratory or cardiovascular disease history)
- •Heterologous blood transfusion in the last 48 hours
- •Weight under 20 kg
结局指标
主要结局
Liquid biopsy analyses
时间窗: Day 0
Extraction of circulating DNA or circulating RNA followed by a tumoral cells extraction.
Standard technics of disease assessment
时间窗: Week 16
Genetic and transcriptomic explorations with immunofluorescence technique. Marking with specific markers of the tumor pathology. And enumaration of tumoral cells.
Correlation between outcome 1 and outcome 2
时间窗: year 5
Building a biological collection of blood samples and following, diagnosis and prediction of adult solid cancer.
次要结局
未报告次要终点
